Could an enzyme produced by white blood cells in response to inflammation reveal hidden heart disease in patients with no symptoms? Do women referred for angioplasty have more symptoms and physical limitations due to angina than their male counterparts? Could the stress of every day life be linked to autonomic dysfunction and contribute to the development of metabolic syndrome (MetS)?
How is depression involved in the literal "heart break" young women experience following a heart attack? Is a link between depression and insulin resistance a key to understanding how it raises heart disease risk?
Could an infection with Chlamydia pneumoniae, known to cause a flu-like illness, be a contributing factor to advanced coronary atherosclerosis? Does being tall increase your risk of atrial fibrillation?
These are a few of the topics Emory Heart Center cardiologists and scientists will be discussing in presentations and panel discussions at the American Heart Association's ( AHA) Scientific Sessions 2004 meeting, slated for November 7 through November 10 in New Orleans at the Ernest N Morial Convention Center. Over 30,000 cardiologists, scientists and other health professionals are slated to attend the meeting which will feature over 3,500 abstracts and a variety of invited programs, lectures and investigative reports in all fields of cardiovascular, cerebrovascular and related disciplines.
"We welcome this exciting opportunity to meet with our colleagues from around the globe in order to share information on the latest advances in cardiovascular medicine, including research that may significantly impact clinical decisions in the future. Emory Heart Center physicians look forward to participating in this comprehensive cardiovascular educational event that plays such a significant role in presenting new heart research and important programs and panels on clinical care issues, "says Douglas C. Morris, M.D., Director of the Emory Heart Center.
On the opening day, November 7th, at 1:30 p.m. (Central Time), Emory scientist Kathy Griendling, PhD, Professor of Medicine in the Emory University School of Medicine Cardiology Division, will receive the AHA's Basic Science Award. The Award is based on the totality of her work as a cardiology researcher.
"We are honored that the AHA has selected Emory scientist Kathy Griendling, Ph.D., to receive the prestigious AHA Basic Research Award," says Dr. Morris. "Dr. Griendling is an excellent example of the creative and dedicated Emory scientists who are working to unravel the causes of cardiovascular disease on a cellular level."